Skip to Content
Jump to the top of the page

Showing 920 – 930 of 1159 results

  • PROCEPT BioRobotics Corporation Initiation

    William Blair initiated research coverage of PROCEPT BioRobotics Corporation (PRCT $31.85), a medical device company focused on creating urology solutions such as the minimally invasive image-guided AquaBeam Robotic System.

  • VistaGen Therapeutics Inc Initiation

    William Blair initiated research coverage of VistaGen Therapeutics, Inc. (VTGN $3.65), a clinical-stage biopharmaceutical company focused on developing next-generation treatment options for social anxiety disorder (SAD) and other neuropsychiatric disorders.

  • Costco Wholesale Corporation Initiation

    William Blair initiated research coverage of Costco Wholesale Corporation (COST $498.65), a big-box retailer offering its membership base exclusive access to discounted prices across groceries, fresh food, general merchandise, services, and gasoline.

  • Paycor HCM Inc Initiation

    William Blair initiated research coverage of Paycor HCM, Inc. (PYCR $26.52), a cloud human capital management (HCM) provider that targets businesses with 10 to 1,000 employees.

  • William Blair Initiates Coverage of Three Companies in the Commercial Aviation Industry

    William Blair initiated research coverage of three companies, which provide aftermarket parts distribution and maintenance, repair, and overhaul services to aviation customers. These include The Boeing Company (BA $237.33), HEICO Corporation (HEI $177.73), and TransDigm Group Incorporated (TDG $972.96).

  • Arcturus Therapeutics Holdings Inc Initiation

    William Blair initiated research coverage of Arcturus Therapeutics Holdings Inc. (ARCT $35.50), a company focused on creating mRNA vaccines and therapies using its proprietary LUNAR mRNA- LNP technologies.

  • Hansa Biopharma AB Initiation

    William Blair initiated research coverage of Hansa Biopharma AB (HNSA SEK 47.06), a biotechnology company focused on the development of the immunoglobin G (IgG)-cleaving enzyme imlifidase for serious diseases driven by IgG antibodies.

  • BellRing Brands Inc Initiation

    William Blair initiated research coverage of BellRing Brands, Inc. (BRBR $35.84), a leading provider of branded nutrition products, ready-to-drink protein shakes, and protein powders.

  • Nayax Ltd Initiation

    William Blair initiated research coverage of Nayax Ltd. (NYAX $16.56), a leading provider of solutions to the unattended retail vertical (e.g., vending, amusement, kiosks).

  • TransMedics Group Inc Initiation

    William Blair initiated research coverage of TransMedics Group, Inc. (TMDX $94.04), the leading provider of organ care systems for end-stage organ failure patients across multiple disease states.

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit www.williamblair.com/disclosures